1. Home
  2. ORGO vs MYN Comparison

ORGO vs MYN Comparison

Compare ORGO & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORGO
  • MYN
  • Stock Information
  • Founded
  • ORGO 1985
  • MYN 1992
  • Country
  • ORGO United States
  • MYN United States
  • Employees
  • ORGO N/A
  • MYN N/A
  • Industry
  • ORGO Biotechnology: Pharmaceutical Preparations
  • MYN Finance Companies
  • Sector
  • ORGO Health Care
  • MYN Finance
  • Exchange
  • ORGO Nasdaq
  • MYN Nasdaq
  • Market Cap
  • ORGO 418.7M
  • MYN 411.5M
  • IPO Year
  • ORGO N/A
  • MYN N/A
  • Fundamental
  • Price
  • ORGO $3.34
  • MYN $10.21
  • Analyst Decision
  • ORGO Strong Buy
  • MYN
  • Analyst Count
  • ORGO 2
  • MYN 0
  • Target Price
  • ORGO $5.00
  • MYN N/A
  • AVG Volume (30 Days)
  • ORGO 607.1K
  • MYN 86.0K
  • Earning Date
  • ORGO 02-27-2025
  • MYN 01-01-0001
  • Dividend Yield
  • ORGO N/A
  • MYN 4.12%
  • EPS Growth
  • ORGO N/A
  • MYN N/A
  • EPS
  • ORGO N/A
  • MYN N/A
  • Revenue
  • ORGO $455,038,000.00
  • MYN N/A
  • Revenue This Year
  • ORGO $9.65
  • MYN N/A
  • Revenue Next Year
  • ORGO $1.57
  • MYN N/A
  • P/E Ratio
  • ORGO N/A
  • MYN N/A
  • Revenue Growth
  • ORGO 1.34
  • MYN N/A
  • 52 Week Low
  • ORGO $2.17
  • MYN $8.47
  • 52 Week High
  • ORGO $4.57
  • MYN $10.62
  • Technical
  • Relative Strength Index (RSI)
  • ORGO 53.23
  • MYN 50.07
  • Support Level
  • ORGO $2.88
  • MYN $10.00
  • Resistance Level
  • ORGO $3.24
  • MYN $10.25
  • Average True Range (ATR)
  • ORGO 0.16
  • MYN 0.09
  • MACD
  • ORGO 0.04
  • MYN 0.02
  • Stochastic Oscillator
  • ORGO 90.29
  • MYN 84.00

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock

Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests primarily in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.

Share on Social Networks: